Latest stories on KTTA
Pasithea Therapeutics Corp. (KTTAW) files 8-K
SEC 8-K50 · neutralgeneral
Pasithea Therapeutics Corp. (KTTAW) files 8-K
SEC 8-K50 · neutralgeneral
Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences
GlobeNewswire56 · neutralgeneral
Pasithea Therapeutics Announces Participation in Two September 2026 Investor Conferences
StockTitan56 · neutralgeneral
Pasithea Therapeutics Receives Nasdaq Extension on Listing Compliance
TipRanks48 · neutralgeneral
Pasithea Therapeutics Corp. (KTTA) files 8-K
SEC 8-K28 · bearishgeneral
Pasithea Therapeutics Announces Presentation of PAS-004 Data to European Society for Medical Oncology (ESMO) Congress 2026
StockTitan56 · neutralproduct/pr
Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit | KTTA Stock News
StockTitan56 · neutralproduct/pr
Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial | KTTA Stock News
StockTitan56 · neutralproduct/pr
Pasithea Therapeutics Announces Exhibit at Children’s Tumor Foundation 2026 NF Conference | KTTA Stock News
StockTitan63 · neutralproduct/pr